awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37702506-035F19A3-C05C-4457-BCDE-CB854EFFB4C4
Q37702506-035F19A3-C05C-4457-BCDE-CB854EFFB4C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37702506-035F19A3-C05C-4457-BCDE-CB854EFFB4C4
Targeted therapy in gastrointestinal malignancies.
P2860
Q37702506-035F19A3-C05C-4457-BCDE-CB854EFFB4C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37702506-035F19A3-C05C-4457-BCDE-CB854EFFB4C4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9bf231d4eb668184511002433662d37a72031035
P2860
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial.